Cargando…
Crohn's disease and ulcerative colitis : from epidemiology and immunobiology to a rational diagnostic and therapeutic approach /
"This new edition is a unique combined resource for physicians and scientists addressing the needs of both groups. In addition to stimulating exchange and collaboration and shortening the path between discovery and application of new knowledge, the book helps clinicians understand new therapeut...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Cham, Switzerland :
Springer,
[2017]
|
| Edición: | Second edition. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn975370122 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 170314t20172017sz abc ob 001 0 eng d | ||
| 040 | |a GW5XE |b eng |e rda |e pn |c GW5XE |d N$T |d EBLCP |d YDX |d UAB |d DKU |d OCLCF |d IOG |d AZU |d UPM |d MERER |d ESU |d OCLCQ |d JBG |d IAD |d ICW |d ICN |d VT2 |d COO |d OTZ |d OCLCQ |d OCLCO |d OCLCA |d U3W |d OCLCA |d GBVCP |d OCLCO |d CAUOI |d MMU |d OCLCO |d OCL |d OCLCO |d OCLCQ |d KSU |d OCLCO |d AU@ |d OCLCO |d OCLCQ |d WYU |d OCLCA |d UKMGB |d OCLCO |d OCLCA |d OCLCQ |d OCLCO |d CASUM |d OCLCO |d AUD |d W2U |d OCLCQ |d OCLCO |d OCLCQ |d ERF |d OCLCQ |d OCLCA |d OCLCQ |d SRU |d ADU |d OCLCQ |d OCLCO |d OCL |d OCLCQ |d OCLCO |d OCLCL |d OCLCQ | ||
| 016 | 7 | |a 019098197 |2 Uk | |
| 019 | |a 974694890 |a 974750486 |a 974969034 |a 975045597 |a 975108538 |a 975224543 |a 975461206 |a 984854983 |a 993545473 |a 993688992 |a 999519273 |a 1005800469 |a 1011851185 |a 1048098114 |a 1058848222 |a 1066458078 |a 1066677864 |a 1086428758 |a 1112589053 |a 1160013962 | ||
| 020 | |a 9783319337036 |q (electronic bk.) | ||
| 020 | |a 3319337033 |q (electronic bk.) | ||
| 020 | |z 9783319337012 |q (hardcover ; |q alk. paper) | ||
| 020 | |z 3319337017 |q (hardcover ; |q alk. paper) | ||
| 024 | 7 | |a 10.1007/978-3-319-33703-6 |2 doi | |
| 024 | 7 | |a 10.1007/978-1-4614-0998-4 |2 doi | |
| 029 | 1 | |a AU@ |b 000059804127 | |
| 029 | 1 | |a GBVCP |b 881510386 | |
| 029 | 1 | |a UKMGB |b 019098197 | |
| 035 | |a (OCoLC)975370122 |z (OCoLC)974694890 |z (OCoLC)974750486 |z (OCoLC)974969034 |z (OCoLC)975045597 |z (OCoLC)975108538 |z (OCoLC)975224543 |z (OCoLC)975461206 |z (OCoLC)984854983 |z (OCoLC)993545473 |z (OCoLC)993688992 |z (OCoLC)999519273 |z (OCoLC)1005800469 |z (OCoLC)1011851185 |z (OCoLC)1048098114 |z (OCoLC)1058848222 |z (OCoLC)1066458078 |z (OCoLC)1066677864 |z (OCoLC)1086428758 |z (OCoLC)1112589053 |z (OCoLC)1160013962 | ||
| 037 | |a com.springer.onix.9783319337036 |b Springer Nature | ||
| 050 | 4 | |a RC862.E52 | |
| 060 | 4 | |a 2017 C-763 | |
| 060 | 4 | |a WI 512 | |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 072 | 7 | |a MJH |2 bicssc | |
| 082 | 0 | 4 | |a 616.3/44 |2 23 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Crohn's disease and ulcerative colitis : |b from epidemiology and immunobiology to a rational diagnostic and therapeutic approach / |c Daniel C. Baumgart, editor. |
| 250 | |a Second edition. | ||
| 264 | 1 | |a Cham, Switzerland : |b Springer, |c [2017] | |
| 264 | 4 | |c ©2017 | |
| 300 | |a 1 online resource (xx, 695 pages) : |b illustrations (chiefly color), color maps | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file | ||
| 347 | |b PDF | ||
| 500 | |a Revised edition of: Crohn's disease and ulcerative colitis : from epidemiology and immunobiology to a rational diagnostic and therapeutic approach / Daniel C. Baumgart, editor. ©2012. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Online resource; title from electronic title page (ProQuest Ebook Central, viewed April 30, 2018). | |
| 505 | 0 | |a Part I: Epidemiology. Environmental factors in the epidemiology of inflammatory bowel disease -- Part II: Immunobiology. Role of the intestinal immune system in health -- Understanding the epithelial barrier in IBD -- Intestinal microbiology and ecology in Crohn's disease and ulcerative colitis -- The immune system in IBD: antimicrobial peptides -- Vascular responses to intestinal inflammation -- Immunobiology of human dendritic cells in inflammatory bowel disease -- Immunobiology of T-cells in inflammatory bowel disease -- Immunobiology of B cells in inflammatory bowel disease -- Immune cells: monocytes and macrophages -- Immune functions of epithelial cells in inflammatory bowel disease -- Autophagy and endoplasmic reticulum stress -- Matrix metalloproteinases -- Paradigm of T cell differentiation in IBD -- Mouse models of chronic intestinal inflammation: characterization and use in pharmacological intervention studies -- Stem cells and organoids to study epithelial cell biology in IBD -- Part III: Diagnostic approach. Enhanced endoscopy -- Magnetic resonance enterography -- Computed tomography enterography and inflammatory bowel disease -- Ultrasound in inflammatory bowel disease -- Laboratory evaluation, including novel diagnostic markers -- Pathology of inflammatory bowel disease -- Objective assessment of clinical disease activity -- Objective assessment of endoscopic disease activity and mucosal healing -- Evaluation of quality of life in Crohn's disease and ulcerative colitis: what is health-related quality of life? -- Evaluation of health economics in inflammatory bowel disease -- Part IV: therapy: Crohn's disease. The natural history of inflammatory bowel disease -- Conventional medical management of Crohn's disease: sulfasalazine -- Steroid therapy for Crohn's disease -- Thiopurines in Crohn's disease -- Conventional medical management of Crohn's disease: methotrexate -- Adalimumab for the treatment of Crohn's disease -- Biologic therapy of Crohn's disease: certolizumab -- Biologic therapy for Crohn's disease: infliximab -- Briakinumab and ustekinumab: anti-p40 antibodies for inflammatory bowel disease treatment -- Biological therapy of Crohn's disease: natalizumab, vedolizumab, and anti-madCAM -- Optimal management of fistulizing Crohn's disease -- Part V: Therapy: ulcerative colitis. Sulfasalazine and 5-aminosalicylates for ulcerative colitis -- Conventional therapy of ulcerative colitis: corticosteroids -- Medical management of ulcerative colitis: conventional therapy--azathioprine -- Calcineurin inhibitors in ulcerative colitis -- Biologic therapy in moderate-to-severe ulcerative colitis: infliximab -- Biologic therapy of ulcerative colitis: adalimumab -- Biologic therapy of ulcerative colitis: golimumab -- Biologic therapy of ulcerative colitis: natalizumab, vedolizumab, etrolizumab (rHUMab beta 7), anti-MAdCAM -- Probiotics, prebiotics, and antibiotics in IBD -- Biosimilars in the treatment of inflammatory bowel disease -- Step-up vs. Top-down approach in Crohn's disease -- Leukocytapheresis therapy of inflammatory bowel disease -- Surgical management of Crohn's disease and ulcerative colitis -- Part VI: Extraintestinal manifestations. Extraintestinal manifestations: autoimmune hepatitis -- Primary sclerosing cholangitis -- Autoimmune pancreatitis and other organ involvement -- Cutaneous and oral manifestations of inflammatory bowel disease -- Arthritis, arthropathy, and osteoporosis in inflammatory bowel disease -- Part VII: Nutrition. Nutrition in inflammatory bowel disease -- Part VIII: Pregnancy, family planning and pediatric aspects. Pregnancy and fertility in inflammatory bowel disease -- Pediatric aspects of inflammatory bowel disease -- Part IX: Surveillance and prevention. Management and prevention of infectious diseases in IBD patients -- Incidence of cancer and screening in inflammatory bowel disease -- Inflammatory bowel diseases: how to identify high-risk patients -- Part X: Patient perspective and resources. Patient perspective on inflammatory bowel disease -- Patient resources in inflammatory bowel disease. | |
| 520 | |a "This new edition is a unique combined resource for physicians and scientists addressing the needs of both groups. In addition to stimulating exchange and collaboration and shortening the path between discovery and application of new knowledge, the book helps clinicians understand new therapeutic concepts from their origins. The volume serves as a comprehensive guide to the current diagnostic modalities, including enhanced imaging techniques such as MRI and CT enterography, virtual colonoscopy, ultrasound, and endomicroscopy, as well as conventional and complex immunomodulatory principles. The latest edition also includes revised chapters from the previous edition, as well as new chapters reflecting current developments in the field. Written by experts in their field, Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach, Second Edition is of great value to gastroenterologists, surgeons, internists, pediatricians and gynecologists trainees, as well as all those involved in Crohn's disease, ulcerative colitis, and related autoimmune disorders"--Publisher's description | ||
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Crohn's disease. | |
| 650 | 0 | |a Ulcerative colitis. | |
| 650 | 2 | |a Colitis, Ulcerative | |
| 650 | 2 | |a Crohn Disease | |
| 650 | 6 | |a Maladie de Crohn. | |
| 650 | 6 | |a Rectocolite hémorragique. | |
| 650 | 7 | |a Gastroenterology. |2 bicssc | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
| 650 | 7 | |a Médecine. |2 eclas | |
| 650 | 7 | |a Ulcerative colitis |2 fast | |
| 650 | 7 | |a Crohn's disease |2 fast | |
| 650 | 7 | |a Crohn-Krankheit |2 gnd | |
| 650 | 7 | |a Colitis ulcerosa |2 gnd | |
| 650 | 7 | |a Crohns sjukdom. |2 sao | |
| 650 | 7 | |a Inflammatoriska tarmsjukdomar. |2 swemesh | |
| 655 | 0 | |a Electronic books. | |
| 655 | 4 | |a Internet Resources. | |
| 700 | 1 | |a Baumgart, Daniel, |e editor. | |
| 730 | 0 | |i Preceded by: |a Crohn's disease and ulcerative colitis. | |
| 758 | |i has work: |a Crohn's disease and ulcerative colitis (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGBtQpvWTMVhhBDq9qgjwd |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Crohn's disease and ulcerative colitis. |b Second edition. |d Cham : Springer, [2017] |z 9783319337012 |w (DLC) 2016959449 |w (OCoLC)978386548 |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=4815400 |z Texto completo |
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL4815400 | ||
| 938 | |a EBSCOhost |b EBSC |n 1219726 | ||
| 938 | |a YBP Library Services |b YANK |n 13528743 | ||
| 994 | |a 92 |b IZTAP | ||